Niche Focus Castle IRB specializes in ethical and compliant IRB reviews for gene and cell therapy clinical trials, presenting a clear entry point for sponsors and CROs focused on advanced therapies seeking expert human subject protection.

Small Team, Agile With a lean team of 2-10 employees, Castle IRB can offer highly responsive review cycles and personalized service, appealing to startups and niche sponsors that require flexible partnerships and faster decision timelines.

Vertical Expansion Position opportunities around expanding gene and cell therapy programs, including late-phase trials and multi-site studies, by offering scalable IRB support tailored to growing sponsors entering advanced therapy initiatives.

Strategic Partnerships There is potential to collaborate with larger IRBs or contract research organizations by providing specialized gene and cell therapy expertise as a complementary partner to handle domain-specific reviews.

Competitive Landscape Castle IRB can differentiate through demonstrated domain expertise in advanced therapies and a client-centric service model to capture market share among smaller sponsors seeking compliant, efficient IRB oversight.